HIF1A and hepatocellular carcinoma: In studies of hepatocellular carcinoma, bufalin was found to down-regulate HIF-1α expression by inhibiting the PI3K/AKT/mTOR signaling pathway, and also to reduce cell invasion by inhibiting the TGF-β-induced EMT process [126,127].